48,474
edits
Difference between revisions of "Uterine tumours"
Jump to navigation
Jump to search
→Adenosarcoma of the uterus
| Line 180: | Line 180: | ||
Clinical:<ref name=pmid17506376>{{Cite journal | last1 = Abu | first1 = J. | last2 = Ireland | first2 = D. | last3 = Brown | first3 = L. | title = Adenosarcoma of an endometrial polyp in a 27-year-old nulligravida: a case report. | journal = J Reprod Med | volume = 52 | issue = 4 | pages = 326-8 | month = Apr | year = 2007 | doi = | PMID = 17506376 }}</ref> | Clinical:<ref name=pmid17506376>{{Cite journal | last1 = Abu | first1 = J. | last2 = Ireland | first2 = D. | last3 = Brown | first3 = L. | title = Adenosarcoma of an endometrial polyp in a 27-year-old nulligravida: a case report. | journal = J Reprod Med | volume = 52 | issue = 4 | pages = 326-8 | month = Apr | year = 2007 | doi = | PMID = 17506376 }}</ref> | ||
*Most common presentations of Müllerian adenosarcoma | *Most common presentations of Müllerian adenosarcoma (percentages based on series of 41 individuals<ref name=pmid9625851>{{Cite journal | last1 = Verschraegen | first1 = CF. | last2 = Vasuratna | first2 = A. | last3 = Edwards | first3 = C. | last4 = Freedman | first4 = R. | last5 = Kudelka | first5 = AP. | last6 = Tornos | first6 = C. | last7 = Kavanagh | first7 = JJ. | title = Clinicopathologic analysis of mullerian adenosarcoma: the M.D. Anderson Cancer Center experience. | journal = Oncol Rep | volume = 5 | issue = 4 | pages = 939-44 | month = | year = | doi = | PMID = 9625851 }}</ref>): | ||
**Vaginal bleeding ~70%. | **Vaginal bleeding ~ 70%. | ||
**Pelvic mass ~40%. | **Pelvic mass ~ 40%. | ||
**Uterine polyp ~30%. | **Uterine polyp ~ 30%. | ||
*Prognosis (based on series of ~500 individuals<ref name=pmid20688363>{{Cite journal | last1 = Arend | first1 = R. | last2 = Bagaria | first2 = M. | last3 = Lewin | first3 = SN. | last4 = Sun | first4 = X. | last5 = Deutsch | first5 = I. | last6 = Burke | first6 = WM. | last7 = Herzog | first7 = TJ. | last8 = Wright | first8 = JD. | title = Long-term outcome and natural history of uterine adenosarcomas. | journal = Gynecol Oncol | volume = 119 | issue = 2 | pages = 305-8 | month = Nov | year = 2010 | doi = 10.1016/j.ygyno.2010.07.001 | PMID = 20688363 }}</ref>): | |||
**Favourable outcome - most detected at an early stage. | |||
***~80% five year survival for stage I tumours. | |||
**Outcome better than [[uterine carcinosarcoma|carcinosarcoma]]. | |||
Treatment: | Treatment: | ||